Fox Chase Cancer Center's John A. Ridge Named President of the American Head and Neck Society
Philadlephia (June 1, 2009) – John A. Ridge, MD, PhD, FACS - Chief, Head and Neck Surgery, Surgical Oncology, chief of head and neck surgery at Fox Chase Cancer Center, has been elected president of the American Head and Neck Society (AHNS). Ridge has been Fox Chase's chief of head and neck surgery since 1991.
Ridge has held many positions within the AHNS organization. The goal of the AHNS is to facilitate and advance knowledge relevant to treatment of diseases of the head and neck, including reconstruction and rehabilitation; promote advancement of the highest professional and ethical standards as they pertain to the practice of major head and neck surgery; and to honor those who have made major contributions in the field of head and neck surgery, or have aided in its advancement. It is the single largest organization in North America for the advancement of research and education in head and neck oncology.
At Fox Chase, Ridge directs clinical research on head and neck cancer and has a strong role in translational research. His clinical practice focuses on head and neck and endocrine tumors, including nonsurgical management, organ preservation, new surgical techniques and early and advanced thyroid tumors.
Ridge is recognized nationally and internationally for his expertise in treating patients with head and neck cancer. In 2006, a grateful patient honored him by establishing and endowing the John A. Ridge Surgical Oncology Fellowship, which provides for the two-year training of a physician in the field of surgical oncology.
Ridge co-chairs the Previously Untreated Locally Advanced Head and Neck Cancer Task Force for the National Cancer Institute (NCI). He has been a member of numerous federal advisory groups, including NCI grant review panels, panels for the National Institute of Dental and Craniofacial Research (NIDCR), the National Institutes of Health/NCI review group for Specialized Program of Research Excellence (SPORE) grants and think tanks on head and neck cancer for NCI and NIDCR.
Fox Chase Cancer Center, part of Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase also was among the first institutions to receive the National Cancer Institute’s prestigious comprehensive cancer center designation in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are routinely recognized in national rankings, and the Center’s nursing program has achieved Magnet status for excellence three consecutive times. Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research and oversees programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX-CHASE (1-888-369-2427).